Proto-Oncogene Proteins c-akt

Displaying 1 - 4 of 4CSV
Ma, L., Pang, Z., Zhang, H., Yang, X., Zheng, S., Chen, Y., Ding, W., Han, Q., Zhang, X., Cao, L., Fei, T., Wang, Q., Gao, D., He, A., Hu, K.-B., Li, X., & Sheng, R. (2025). Clear cell renal carcinoma essentially requires CDKL3 for oncogenesis. Proceedings of the National Academy of Sciences, 122(7). https://doi.org/10.1073/pnas.2415244122
Publication Date
Rogava, M., Aprati, T. J., Chi, W.-Y., Melms, J. C., Hug, C., Davis, S. H., Earlie, E. M., Chung, C., Deshmukh, S. K., Wu, S., Sledge, G., Tang, S., Ho, P., Amin, A. D., Caprio, L., Gurjao, C., Tagore, S., Ngo, B., Lee, M. J., … Izar, B. (2024). Loss of Pip4k2c confers liver-metastatic organotropism through insulin-dependent PI3K-AKT pathway activation. Nature Cancer, 5(3), 433–447. https://doi.org/10.1038/s43018-023-00704-x
Publication Date
Searle, B. C., Chien, A., Koller, A., Hawke, D., Herren, A. W., Kim Kim, J., Lee, K. A., Leib, R. D., Nelson, A. J., Patel, P., Ren, J. M., Stemmer, P. M., Zhu, Y., Neely, B. A., & Patel, B. (2023). A Multipathway Phosphopeptide Standard for Rapid Phosphoproteomics Assay Development. Molecular & Cellular Proteomics, 22(10), 100639. https://doi.org/10.1016/j.mcpro.2023.100639
Publication Date
Sasako, T., Umehara, T., Soeda, K., Kaneko, K., Suzuki, M., Kobayashi, N., Okazaki, Y., Tamura-Nakano, M., Chiba, T., Accili, D., Kahn, C. R., Noda, T., Asahara, H., Yamauchi, T., Kadowaki, T., & Ueki, K. (2022). Deletion of skeletal muscle Akt1/2 causes osteosarcopenia and reduces lifespan in mice. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-33008-2
Publication Date